CINDY BERNARD: Open Payments
NPI 1285240077 · WILLOW PARK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,370 in 22 payments from 14 companies in 2025. Trend: 2023 $1,500 · 2024 $2,018 · 2025 $1,370
Food & beverage: $1,350Long term medical supply or device loan: $20
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $409 |
| Lilly USA, LLC | 3 | $160 |
| Corcept Therapeutics | 1 | $127 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $121 |
| SANOFI-AVENTIS U.S. LLC | 1 | $119 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $91 |
| Paratek Pharmaceuticals, Inc. | 1 | $54 |
| Abbott Laboratories | 2 | $42 |
| Exact Sciences Corporation | 2 | $33 |
Products named: MOUNJARO, Korlym, GATTEX, TZIELD, Wegovy, XIFAXAN, Ozempic, NUZYRA.
Industry payments across TX — which companies pay providers there.
